文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

ICU中的肾脏清除率增强:估计、发生率、危险因素及后果——一项回顾性观察研究

Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences-a retrospective observational study.
PubMed 文献 · Ann Intensive Care · 2022-09-26
一句话结论ICU患者中肾脏清除率增强(ARC)总体发生率为24.6%,第5天达峰值,年轻且无心血管合并症者风险更高,ARC持续超过ICU时间10%与30天死亡风险降低相关。

本研究为法国Bichat医院内科ICU的回顾性单中心观察研究,纳入2017年1月1日至2020年11月31日期间首次入住ICU且ICU停留超过72小时、年龄大于18岁的患者,排除慢性肾脏病患者,共312例。每日用实测肌酐肾脏清除率(CrCl)估算肾小球滤过率,ARC定义为24小时CrCl大于130 ml/min/m2。ARC总体发生率为24.6%,第5天达峰值;危险因素为年轻和 absence of cardiovascular comorbidities;ARC持续超过ICU停留时间10%与30天死亡风险降低显著相关。作者结论认为ARC在ICU常见,ICU第一周发生率升高,需进一步研究评估其对患者预后的影响。

要点

  • 312例内科ICU患者中ARC总体发生率为24.6%,峰值出现在ICU第5天。
  • ARC危险因素为年轻和 absence of cardiovascular comorbidities。
  • ARC持续超过ICU停留时间10%与30天死亡风险降低显著相关。
  • ARC定义为24小时实测肌酐肾脏清除率(CrCl)大于130 ml/min/m2。
  • 研究排除慢性肾脏病患者,纳入ICU停留超过72小时且年龄大于18岁的首次入ICU患者。

适用人群与场景

  • 2017年1月1日至2020年11月31日期间首次入住法国APHP大学医院Bichat内科ICU、年龄大于18岁、ICU停留时间超过72小时并纳入Outcomerea数据库的患者。
  • 排除慢性肾脏病患者。

诊断标准与关键阈值

  • ARC定义为24小时实测肌酐肾脏清除率(CrCl)大于130 ml/min/m2。
  • 每日用实测肌酐肾脏清除率(CrCl)估算肾小球滤过率。

研究设计与关键结果

  • 研究类型为回顾性、单中心、观察性研究,共纳入312例患者。
  • 中位年龄62.7岁[51.4; 71.8],106例(31.9%)有慢性心血管疾病。
  • 主要入ICU原因为急性呼吸衰竭(184例,59%),196例(62.8%)为SARS-COV2感染。
  • SAPS II评分中位值32[24; 42.5];146例(44%)使用血管升压药,154例(46.4%)接受有创机械通气。
  • ARC总体发生率为24.6%,峰值出现在ICU第5天。
  • ARC发生的危险因素为年轻和 absence of cardiovascular comorbidities。
  • ARC持续超过ICU停留时间10%与30天死亡风险降低显著相关。

证据类型、等级与局限

  • 证据类型:回顾性、单中心、观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ARC在ICU常见,ICU第一周发生率升高。
  • 作者认为需进一步研究评估ARC对患者预后的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Augmented renal clearance (ARC) remains poorly evaluated in ICU. The objective of this study is to provide a full description of ARC in ICU including prevalence, evolution profile, risk factors and outcomes.

METHODS: This was a retrospective, single-center, observational study. All the patients older than 18 years admitted for the first time in Medical ICU, Bichat, University Hospital, APHP, France, between January 1, 2017, and November 31, 2020 and included into the Outcomerea database with an ICU length of stay longer than 72 h were included. Patients with chronic kidney disease were excluded. Glomerular filtration rate was estimated each day during ICU stay using the measured creatinine renal clearance (CrCl). Augmented renal clearance (ARC) was defined as a 24 h CrCl greater than 130 ml/min/m2.

RESULTS: 312 patients were included, with a median age of 62.7 years [51.4; 71.8], 106(31.9%) had chronic cardiovascular disease. The main reason for admission was acute respiratory failure (184(59%)) and 196(62.8%) patients had SARS-COV2. The median value for SAPS II score was 32[24; 42.5]; 146(44%) and 154(46.4%) patients were under vasopressors and invasive mechanical ventilation, respectively. The overall prevalence of ARC was 24.6% with a peak prevalence on Day 5 of ICU stay. The risk factors for the occurrence of ARC were young age and absence of cardiovascular comorbidities. The persistence of ARC during more than 10% of the time spent in ICU was significantly associated with a lower risk of death at Day 30.

CONCLUSION: ARC is a frequent phenomenon in the ICU with an increased incidence during the first week of ICU stay. Further studies are needed to assess its impact on patient prognosis.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Egea A, Dupuis C, de Montmollin E, et al. Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences-a retrospective observational study. Ann Intensive Care. 2022. PMID: 36156744. doi:10.1186/s13613-022-01058-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。